Relevant bibliographies by topics / Australian Medical Research Institute

Academic literature on the topic 'Australian Medical Research Institute'

Author: Grafiati
Published: 10 December 2022
Last updated: 28 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Australian Medical Research Institute.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Australian Medical Research Institute"

1

Hickie, Ian B., Ian B. Hickie, Helen Christensen, Tracey A. Davenport, and Georgina M. Luscombe. "Can We Track the Impact of Australian Mental Health Research?" Australian & New Zealand Journal of Psychiatry 39, no. 7 (July 2005): 591–99. http://dx.doi.org/10.1080/j.1440-1614.2005.01631.x.

Full text
Abstract:
Objective: Arguments are being made to increase research and development funding for mental health research in Australia. Consequently, the methods used to measure the results of increased investment require review. This study aimed to describe the status of Australian mental health research and to propose potential methods for tracking changes in research output. Specifically, we describe the research output of nations, Australian states, Australian and New Zealand institutions and Australian and New Zealand researchers using citation rates. Method: Information on research output was sourced from two international databases (Institute for scientific information [ISI] Essential Science Indicators and ISI Web of Science) and the ISI list of Highly Cited Researchers. Results: In an international setting, Australia does not perform as well as other comparable countries such as New Zealand or Canada in terms of research output. Within Australia, the scientific performance of institutions apparently relates to the strength of some individual researchers or consolidated research groups. Highly cited papers are evident in the fields of syndrome definition, epidemiology and epidemiological methods, cognitive science and prognostic or longitudinal studies. Conclusions: Australian researchers need to consider the success of New Zealand and Canadian researchers, particularly given the relatively low investment in health and medical research in New Zealand. Although citation analyses are fraught with difficulties, they can be effectively complemented by other measures of responsiveness to clinical or population needs and community expectations and should be conducted regularly and independently to monitor the status of Australian mental health research.
APA, Harvard, Vancouver, ISO, and other styles
2

Hobbins, Peter G. "Serpentine Science: Charles Kellaway and the Fluctuating Fortunes of Venom Research in Interwar Australia." Historical Records of Australian Science 21, no. 1 (2010): 1. http://dx.doi.org/10.1071/hr09012.

Full text
Abstract:
Australian medical research before the Second World War is predominantly viewed as an anodyne precursor to its conspicuous postwar successes. However, the expanding intellectual appeal and state support for local research after 1945 built upon scientific practices, networks, facilities and finances established between 1919 and 1939. Arguably the most prominent medical scientist working in Australia during this period was Charles Kellaway (1889?1952), director of Melbourne's Walter and Eliza Hall Institute from 1923 until 1944. Facing both financial challenges and a profoundly unsupportive intellectual climate, Kellaway instigated a major research programme into Australian snake venoms. These investigations garnered local and international acclaim, allowing Kellaway to speak as a significant scientific actor while fostering productive laboratory collaborations. The venom work spurred basic research in tissue injury, anaphylaxis and leukotriene pharmacology, yet delivered pragmatic clinical outcomes, particularly an effective antivenene. By selecting a problem of continuing public interest, Kellaway also stimulated wider engagement with science and initiated a pioneering ad hoc Commonwealth grant for medical research. In tracing his training, mentors and practices within the interwar milieu, this article argues that Kellaway's venom studies contributed materially to global biomedical developments and to the broader viability of medical research in Australia.
APA, Harvard, Vancouver, ISO, and other styles
3

Renwick, Manoa. "Quality Assurance in Australian Hospitals: How Far Does it Go?" Australian Medical Record Journal 18, no. 3 (September 1988): 97–101. http://dx.doi.org/10.1177/183335838801800304.

Full text
Abstract:
The Australian Institute of Health (AIH) surveyed all acute hospitals in Australia to discover the extent of quality assurance (QA) activities, the types of programs being run and the processes being used. This paper explains the Institute's research strategy and puts the survey into the context of QA in Australia today. It describes the research method, identifies sources of bias, and presents some of the results. These show that medical record administrators (MRAs) play an active role in QA by coordinating hospital programs, by implementing individual reviews of their own departments, and by servicing other departmental reviews. The results pertaining to the extent and nature of QA are discussed and it is concluded that there seems to be some review of the quality of care for the majority of hospital patients. The effectiveness of that review, and whether or not it is quality assurance, still has to be investigated. (AMRJ 1988, 18(3), 97–101).
APA, Harvard, Vancouver, ISO, and other styles
4

Crowe, B. L., and I. G. Mcdonald. "Telemedicine in Australia. Recent developments." Journal of Telemedicine and Telecare 3, no. 4 (December 1, 1997): 188–93. http://dx.doi.org/10.1258/1357633971931147.

Full text
Abstract:
There have been a number of important developments in Australia in the area of telemedicine. At the national level, the House of Representatives' Standing Committee on Family and Community Affairs has been conducting the Inquiry into Health Information Management and Telemedicine. The Australian Health Ministers' Advisory Council has supported the establishment of a working party convened by the South Australian Health Commission to prepare a detailed report on issues relating to telemedicine. State governments have begun a number of telemedicine projects, including major initiatives in New South Wales and Victoria and the extensive development of telepsychiatry services in Queensland. Research activities in high-speed image transmission have been undertaken by the Australian Computing and Communications Institute and Telstra, and by the Australian Navy. The matter of the funding of both capital and recurrent costs of telemedicine services has not been resolved, and issues of security and privacy of medical information are subject to discussion. The use of the Internet as a universal communications medium may provide opportunities for the expansion of telemedicine services, particularly in the area of continuing medical education. A need has been recognized for the coordinated evaluation of telemedicine services as cost-benefit considerations are seen to be very important.
APA, Harvard, Vancouver, ISO, and other styles
5

Lee, Jessica D. Y., and Lyle J. Palmer. "The Western Australian Twin Register: A Population-Based Register of Adult and Child Multiples." Twin Research and Human Genetics 9, no. 6 (December 1, 2006): 712–17. http://dx.doi.org/10.1375/twin.9.6.712.

Full text
Abstract:
AbstractThe Western Australian Twin Register (WATR) was established in 1997 to study the health of all child multiples born in Western Australia (WA). The Register has until recently consisted of all multiples born in WA between 1980 and 1997. Using unique record linkage capacities available through the WA data linkage system, we have subsequently been able to identify all multiple births born in WA since 1974. New affiliations with the Australian Twin Registry and the WA Institute for Medical Research are further enabled by the use of the WA Genetic Epidemiology Resource — a high-end bioinformatics infrastructure that allows efficient management of health datasets and facilitates collaborative research capabilities. In addition to this infrastructure, funding provided by these institutions has allowed the extension of the WATR to include a greater number of WA multiples, including those born between 1974 and 1979, and from 1998 onwards. These resources are in the process of being enabled for national and international access.
APA, Harvard, Vancouver, ISO, and other styles
6

Buckley, Jonathan, Malcolm Riley, Lisa Wood, Sheila Skeaff, and Manny Noakes. "Abstracts of the 10th Asia-Pacific Conference on Clinical Nutrition." Proceedings 2, no. 12 (August 9, 2018): 573. http://dx.doi.org/10.3390/proceedings2120573.

Full text
Abstract:
The Asia-Pacific Conference on Clinical Nutrition is a biennial conference held within the Asia-Pacific region. The 2017 meeting was a joint meeting of the Asia-Pacific Society of Clinical Nutrition, the Nutrition Society of Australia and the Nutrition Society of New Zealand. The meeting was hosted by CSIRO Health and Biosecurity in collaboration with the University of South Australia, the University of Adelaide, Flinders University and the South Australian Health and Medical Research Institute. The theme of the meeting was Nutrition Solutions for a Changing World. Four hundred and thirty-eight registrants attended the conference and 432 papers were presented. This issue presents the proceedings of this meeting in the form of abstracts for each paper that was presented at the conference.
APA, Harvard, Vancouver, ISO, and other styles
7

Buckley, Jonathan, Malcolm Riley, Lisa Wood, Sheila Skeaff, and Manny Noakes. "Abstracts of the 10th Asia-Pacific Conference on Clinical Nutrition." Proceedings 2, no. 12 (August 9, 2018): 573. http://dx.doi.org/10.3390/proceedings21210573.

Full text
Abstract:
The Asia-Pacific Conference on Clinical Nutrition is a biennial conference held within the Asia-Pacific region. The 2017 meeting was a joint meeting of the Asia-Pacific Society of Clinical Nutrition, the Nutrition Society of Australia and the Nutrition Society of New Zealand. The meeting was hosted by CSIRO Health and Biosecurity in collaboration with the University of South Australia, the University of Adelaide, Flinders University and the South Australian Health and Medical Research Institute. The theme of the meeting was Nutrition Solutions for a Changing World. Four hundred and thirty-eight registrants attended the conference and 432 papers were presented. This issue presents the proceedings of this meeting in the form of abstracts for each paper that was presented at the conference.
APA, Harvard, Vancouver, ISO, and other styles
8

Angus, James A. "SYMBIOTIC RELATIONSHIP BETWEEN A RESEARCH INSTITUTE AND A PHARMACEUTICAL COMPANY: THE BAKER INSTITUTE/GLAXO AUSTRALIA STORY." Clinical and Experimental Pharmacology and Physiology 19, no. 1 (January 1992): 67–71. http://dx.doi.org/10.1111/j.1440-1681.1992.tb00400.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hopper, John L., Debra L. Foley, Paul A. White, and Vincent Pollaers. "Australian Twin Registry: 30 Years of Progress." Twin Research and Human Genetics 16, no. 1 (December 3, 2012): 34–42. http://dx.doi.org/10.1017/thg.2012.121.

Full text
Abstract:
The Australian Twin Registry (ATR) is a national volunteer resource of twin pairs and higher-order multiples willing to consider participating in health, medical, and scientific research. The vision of the ATR is ‘to realize the full potential of research involving twins to improve the health and well-being of all Australians’. The ATR has been funded continuously by the National Health and Medical Council for more than 30 years. Its core functions entail the recruitment and retention of twin members, the maintenance of an up-to-date database containing members’ contact details and baseline information, and the promotion and provision of open access to researchers from all institutes in Australia, and their collaborators, in a fair and equitable manner. The ATR is administered by The University of Melbourne, which acts as custodian. Since the late 1970s the ATR has enrolled more than 40,000 twin pairs of all zygosities and facilitated more than 500 studies that have produced at least 700 peer-reviewed publications from classical twin studies, co-twin control studies, within-pair comparisons, twin family studies, longitudinal twin studies, randomized controlled trials, and epigenetics studies, as well as studies of issues specific to twins. New initiatives include: a Health and Life Style Questionnaire; data collection, management, and archiving using a secure online software program (The Ark); and the International Network of Twin Registries. The ATR's expertise and 30 years of experience in providing services to national and international twin studies has made it an important resource for research across a broad range of disciplines.
APA, Harvard, Vancouver, ISO, and other styles
10

Budd, Alison C., and Christine J. Sturrock. "Cytology and cervical cancer surveillance in an era of human papillomavirus vaccination." Sexual Health 7, no. 3 (2010): 328. http://dx.doi.org/10.1071/sh09133.

Full text
Abstract:
Cytological and cancer surveillance will provide the most effective indications of short-term effects and long-term outcomes of the introduction of the human papillomavirus (HPV) vaccine in Australia. This article outlines how this surveillance is proposed to occur through the established national monitoring mechanisms of the National Cervical Screening Program in the annual Australian Institute of Health and Welfare (AIHW) publication ‘Cervical screening in Australia’. Cytological surveillance will be possible principally through cytology data provided annually by the state and territory cervical cytology registers, and it is expected that these data will provide the earliest and most comprehensive indications of effects from the HPV vaccine. Some potential issues in interpreting these data are also discussed, including the potentially confounding effects of the introduction of new National Health and Medical Research Council guidelines ‘Screening to prevent cervical cancer: guidelines for the management of asymptomatic women with screen-detected abnormalities’ some 9 months before the introduction of the vaccine. Cancer surveillance over the long term will be possible using cervical cancer incidence data reported annually for the National Cervical Screening Program in ‘Cervical screening in Australia’ using data sourced from the Australian Cancer Database. In a final discourse, the HPV vaccine and cervical screening are discussed concurrently, and the importance of continued cervical screening in the HPV vaccine era emphasised.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Australian Medical Research Institute"

1

Williams, Stephen John, and n/a. "A case study of the relationship between sports science research practice and elite coaches' perceived needs." University of Canberra. Health Sciences, 2005. http://erl.canberra.edu.au./public/adt-AUC20060530.101909.

Full text
Abstract:
Elite coaches consider aspects of sports science when preparing athletes for competition. Sports scientists conduct applied research and a fundamental purpose of sports science research is to produce knowledge that helps improve the performance of elite athletes. In view of the considerable resources being directed toward research and coaching at the elite level, there is a need to conduct research to identify the relationship between research and coaching practice at the elite level. Australia has an institute of sport or academy of sport in each state and territory dedicated to the development of team and individual sports, both Olympic and non- Olympic. In the area of elite athlete performance, the Australian Institute of Sport (AIS) has gained an international reputation for excellence, and the AIS Research Centre has achieved international recognition for the quality of research projects directed toward the performance of elite athletes. Sports scientists at Australian universities also undertake research related to elite coaching, some of which has occurred in partnership with researchers at Australian institutes of sport. The purpose of the study was to identify the relationship between sports science research at Australian institutes of sport and post-graduate sports science research in Australian universities, and how elite coaches in Australia perceive sports science research practice meeting the needs of elite coaching. A case study method was selected for this thesis, which involved the following data gathering instruments: a survey of 225 elite coaches and 125 sports science researchers, follow-up interviews of elite coaches and sports science researchers, and document analysis of 725 research projects conducted at Australian institutes of sport and postgraduate theses at Master and Doctoral level at Australian universities. An analysis was also conducted to assess the sports science content contained in the National Coaching Accreditation Scheme's Level Three course material. A schedule was developed for the document analysis called the "Williams Sports Science Research Schedule". Interviews were conducted with elite key informants to validate a model that was developed fiom the study. Results of the study revealed a degree of congruence between the perceptions of elite coaches and sports science researchers regarding the research needs of elite coaches and the research activity of sports science researchers. A model, called the "Elite Sports Research Model" was developed to describe that relationship. The Elite Sports Research Model contains four components, namely: coach knowledge, information seeking/dissemination strategies, qualities valued in an elite coach and a sports science researcher, and application of research. Within the model, particular perspectives of elite coaches and particular perspectives of sports science researchers were identified. Some differences were found between elite coaches of team sports and elite coaches of individual sports, as well as some differences between researchers at institutes of sports and researchers at universities. At the elite level in Australia a relationship was found between sports science research activity and the research needs of elite coaches. With the increase in support for elite coaching and sports science research in Australia and internationally, the results of this study should help to inform improvement in sports science research programs that support elite coaching practice.
APA, Harvard, Vancouver, ISO, and other styles
2

Erdey, Nancy Carol. "Armor of patience : the National Cancer Institute and the development of medical research policy in the United States, 1937-1971 /." Diss., Case Western Reserve University School of Graduate Studies / OhioLINK, 1995. http://www.ohiolink.edu/etd/view.cgi?acc%5Fnum=case1058363714.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Huan, Xiang Quan. "Depot cytokines and chemokines for antitumor therapy in a mouse model /." [St. Lucia, Qld.], 2004. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe18435.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Anraku, Itaru. "Induction of long lasting protective CD8+ T lymphocyte responses by Kunjin replicon-based vaccine vectors /." [St. Lucia, Qld.], 2005. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe18960.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ye, Mao. "Project management for quality control research of traditional Chinese medicine based on technological innovation." Thesis, University of Macau, 2008. http://umaclib3.umac.mo/record=b2159438.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Scaife, Wendy A. "Transforming human energy to power for change : development principles for charitable health organisations seeking to optimise community and other support of Australian medical science." Thesis, Queensland University of Technology, 2002. https://eprints.qut.edu.au/36364/1/36364_Digitised%20Thesis.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Senate, University of Arizona Faculty. "Faculty Senate Minutes January 27, 2014." University of Arizona Faculty Senate (Tucson, AZ), 2014. http://hdl.handle.net/10150/312203.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Vice, President Research Office of the. "Newswire." Office of the Vice President Research, The University of British Columbia, 2008. http://hdl.handle.net/2429/2661.

Full text
Abstract:
UBC's research community recently received a significant boost in financial support for five research hubs that will join the Centre for Brain Health as newly appointed national Centres of Excellence for Commercialization and Research (CECR). Two UBC economics professors were recognized with separate Bank of Canada awards: the Research Fellowship 2008 and the Governor's Award. UBC's Brain Research Centre has recevied $25 million from the Province of BC to establish a new facility focused on translational brain research.
APA, Harvard, Vancouver, ISO, and other styles
9

Derrick, G. E. "Institutionalising the agora : investigating the evolution of public accountability in Australian medical research institutes." Phd thesis, 2009. http://hdl.handle.net/1885/149722.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Tseng, Wen Chih, and 曾文智. "Research on Clinical Genetic Test -- Test Institute, Professional, and Medical device." Thesis, 2005. http://ndltd.ncl.edu.tw/handle/94717460328057329220.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Australian Medical Research Institute"

1

Legge, J. D. Australian outlook: A history of the Australian Institute of International Affairs. St. Leonards, NSW: Allen & Unwin in association with the Australian Institute of International Affairs and the Dept. of International Relations, Research School of Pacific and Asian Studies, Australian National University, Canberra, ACT, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

The National Institute of General Medical Sciences. [Bethesda, Md.]: National Institutes of Health, National Institute of General Medical Sciences, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

National Institute of General Medical Sciences (U.S.). Annual report : National Institute of General Medical Sciences. [Bethesda, Md.]: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health., 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Whithear, Deborah. Australian Institute of Family Studies: Collected works 1980-2001. Melbourne: Australian Institute of Family Studies, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Diseases, U. S. Army Medical Research Institute of Infectious. United States Army Medical Research Institute of Infectious Diseases. Frederick, MD: USAMRIID, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

The Howard Hughes Medical Institute: A twentieth century history. Chevy Chase, Md: Howard Hughes Medical Institute, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

(India), Institute for Research in Medical Statistics. Institute for Research in Medical Statistics, Indian Council of Medical Research: Silver jubilee : highlights of achievements. New Delhi: Institute for Research in Medical Statistics, Indian Council of Medical Research, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

(India), Institute for Research in Medical Statistics. Institute for Research in Medical Statistics, Indian Council of Medical Research: Silver jubilee : highlights of achievements. New Delhi: Institute for Research in Medical Statistics, Indian Council of Medical Research, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Buscher, Leo F. National Cancer Institute grants process. [Bethesda, Md.?]: National Cancer Institute, U.S. Dept. of Health and Human Services, National Institutes of Health, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Western Australian Mining and Petroleum Research Institute. Western Australian Mining and Petroleum Research Institute: Final report, 1987/88 to 31 January 1988. Perth, W.A: The Institute, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Australian Medical Research Institute"

1

Elliott, Denielle. "The Kenya Medical Research Institute." In Reimagining Science and Statecraft in Postcolonial Kenya, 94–108. New York : Routledge, 2018. | Series: Routledge contemporary Africa series: Routledge, 2018. http://dx.doi.org/10.4324/9781315163840-15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Baker, Joe. "Interdisciplinary Oceanographic Studies at the Australian Institute of Marine Science." In New Directions of Oceanographic Research and Development, 3–14. Tokyo: Springer Japan, 1993. http://dx.doi.org/10.1007/978-4-431-68225-7_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Medawar, P. B. "Animal Experimentation in a Medical Research Institute 1." In The Hope of Progress, 77–86. London: Routledge, 2021. http://dx.doi.org/10.4324/9781003221616-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bokros, Jack. "Medical Carbon Research Institute LLC/On-X Life Technologies Inc." In Heart of Carbon, 137–40. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-17933-4_19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Haschke, Ferdinand, and Petra Klassen-Wigger. "Sustainable Clinical Research, Health Economic Aspects and Medical Marketing: Drivers of Product Innovation." In Nestlé Nutrition Institute Workshop Series: Pediatric Program, 125–41. Basel: KARGER, 2010. http://dx.doi.org/10.1159/000318953.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Cao, Zhiying. "Research on Medical Information Processing Based on Data Mining Technology." In Lecture Notes of the Institute for Computer Sciences, Social Informatics and Telecommunications Engineering, 510–16. Cham: Springer Nature Switzerland, 2022. http://dx.doi.org/10.1007/978-3-031-18123-8_39.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Wang, Yixin, Weiqing Fang, Wei Zhu, and Jinshun Ding. "Research on Multi-agency Data Fusion Mode Under Regional Medical Integration." In Lecture Notes of the Institute for Computer Sciences, Social Informatics and Telecommunications Engineering, 267–77. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-82565-2_22.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Wang, Xiao-yan, Guo-hui Wei, Zheng-wei Gu, Jin-gang Ma, Ming Li, and Hui Cao. "Research on Scale Space Fusion Method of Medical Big Data Video Image." In Lecture Notes of the Institute for Computer Sciences, Social Informatics and Telecommunications Engineering, 394–402. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-51100-5_35.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Chu, Wan-Loy, Eng-Lai Tan, Stephen Ambu, Chee-Onn Leong, Vishna Devi Nadarajah, Patricia Kim-Chooi Lim, Shew-Fung Wong, Geok-Lin Khor, James Michael Menke, and Joon-Wah Mak. "Institute for Research, Development and Innovation (IRDI) of the International Medical University (IMU), Malaysia." In The Malaysia-Japan Model on Technology Partnership, 387–95. Tokyo: Springer Japan, 2014. http://dx.doi.org/10.1007/978-4-431-54439-5_39.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Grace, Delia, Silvia Alonso, Bernard Bett, Elizabeth Cook, Hu Suk Lee, Anne Liljander, Jeff Mariner, et al. "Zoonoses." In The impact of the International Livestock Research Institute, 302–37. Wallingford: CABI, 2020. http://dx.doi.org/10.1079/9781789241853.0302.

Full text
Abstract:
Abstract This book chapter focuses on zoonoses that are not transmitted primarily through food. Establishing systematic data collection is the first step to manage zoonoses. Management is complicated by heterogeneity: zoonoses may have a significant and debilitating effect on some communities but not on others. Understanding the spatial distribution of the burden of zoonoses is important to better focus control efforts. A significant constraint is the lack of collaboration between medical and veterinary authorities: institutionally speaking, zoonoses typically find themselves homeless and ignored. There is a need for one-health thinking and research to overcome inter-sectoral barriers to effective control of zoonoses.
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Australian Medical Research Institute"

1

Lamuri, Aly, Randy Sarayar, Jonathan Purba, and Adrian Sudirman. "Graph Database on Medical Research Data for Integrated Life Science Research." In The annual International Conference and Exhibition on Indonesian Medical Education and Research Institute. SCITEPRESS - Science and Technology Publications, 2019. http://dx.doi.org/10.5220/0009387000050011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Argentini, M., J. Arkuszewski, John F. Crawford, B. Larsson, Jiri Stepanek, Sarah Teichmann, and R. Weinreich. "Boron neutron capture therapy at the Institute of Medical Radiobiology (IMR) and Paul Scherrer Institute (PSI)." In Fifth International Conference on Applications of Nuclear Techniques: Neutrons in Research and Industry, edited by George Vourvopoulos. SPIE, 1997. http://dx.doi.org/10.1117/12.267843.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Stres, Spela. "A cyclotron project for medical and research usage at Jožef Stefan Institute." In 2008 IEEE Nuclear Science Symposium and Medical Imaging conference (2008 NSS/MIC). IEEE, 2008. http://dx.doi.org/10.1109/nssmic.2008.4775004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Siswanto, Putri, and Riries Rulaningtyas. "Artificial Neural Network and Its Application in Medical Disease Prediction: Review Article." In The annual International Conference and Exhibition on Indonesian Medical Education and Research Institute. SCITEPRESS - Science and Technology Publications, 2019. http://dx.doi.org/10.5220/0009387400170025.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Nuranna, Laila, Gatot Purwoto, Annisa Sukana, and Alexander Peter. "TeleDoVIA Meeting the Challenge of Early Detection on Cervical Cancer: A Pilot Study in Indonesia." In The annual International Conference and Exhibition on Indonesian Medical Education and Research Institute. SCITEPRESS - Science and Technology Publications, 2019. http://dx.doi.org/10.5220/0009387200120016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Aditianingsih, Dita, Besthadi Sukmono, Erika Adiwongso, and Chaidir Mochtar. "Effect of Pre-incisional Ultrasound-guided Quadratus Lumborum Block on Perioperative Analgesia and Inflammatory Responses in Transperitoneal Laparoscopic Nephrectomy: A Single-blinded, Randomised Control Trial." In The annual International Conference and Exhibition on Indonesian Medical Education and Research Institute. SCITEPRESS - Science and Technology Publications, 2019. http://dx.doi.org/10.5220/0009387900260032.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Sipa, Donni Maulana, and Jamrud Aminuddin. "Determination of Thorax Exposure Factors in Conventional X-rays Imaging using the Artificial Neural Network Method." In The annual International Conference and Exhibition on Indonesian Medical Education and Research Institute. SCITEPRESS - Science and Technology Publications, 2019. http://dx.doi.org/10.5220/0009388100330037.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Nugraha, Krishna, M. Fadlan, Dea Kurniawan, Liemena Adrian, Faris Nugroho, Puspa Lestari, Seprian Widasmara, Anita Santoso, and Mohammad Rohman. "The Symptoms-based Algorithm for Early Detection of Systolic Heart Failure." In The annual International Conference and Exhibition on Indonesian Medical Education and Research Institute. SCITEPRESS - Science and Technology Publications, 2019. http://dx.doi.org/10.5220/0009388300380041.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Santoso, Anita Surya, Krishna Ari Nugraha, M. Rizki Fadlan, Dea Arie Kurniawan, Liemena Harold Adrian, Faris Wahyu Nugroho, Puspa Lestari, Seprian Widasmara, and Mohammad Saifur Rohman. "Saiful Anwar Hospital Heart Failure Registry (SAHEFAR): A Valuable Tool for Improving the Management of Patients with Heart Failure in Malang, East Java." In The annual International Conference and Exhibition on Indonesian Medical Education and Research Institute. SCITEPRESS - Science and Technology Publications, 2019. http://dx.doi.org/10.5220/0009388400420047.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Pramudya, Astrid, Mohammad Rohman, Muhamad Fadlan, Liemena Adrian, Faris Nugroho, Monika Sitio, Diah Ivanasari, and Ardani Prakosa. "Increasing Health Care Provider Awareness on Cardiovascular Disease by Malang Cardiovascular Networking System." In The annual International Conference and Exhibition on Indonesian Medical Education and Research Institute. SCITEPRESS - Science and Technology Publications, 2019. http://dx.doi.org/10.5220/0009388500480052.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Australian Medical Research Institute"

1

Rankin, Nicole, Deborah McGregor, Candice Donnelly, Bethany Van Dort, Richard De Abreu Lourenco, Anne Cust, and Emily Stone. Lung cancer screening using low-dose computed tomography for high risk populations: Investigating effectiveness and screening program implementation considerations: An Evidence Check rapid review brokered by the Sax Institute (www.saxinstitute.org.au) for the Cancer Institute NSW. The Sax Institute, October 2019. http://dx.doi.org/10.57022/clzt5093.

Full text
Abstract:
Background Lung cancer is the number one cause of cancer death worldwide.(1) It is the fifth most commonly diagnosed cancer in Australia (12,741 cases diagnosed in 2018) and the leading cause of cancer death.(2) The number of years of potential life lost to lung cancer in Australia is estimated to be 58,450, similar to that of colorectal and breast cancer combined.(3) While tobacco control strategies are most effective for disease prevention in the general population, early detection via low dose computed tomography (LDCT) screening in high-risk populations is a viable option for detecting asymptomatic disease in current (13%) and former (24%) Australian smokers.(4) The purpose of this Evidence Check review is to identify and analyse existing and emerging evidence for LDCT lung cancer screening in high-risk individuals to guide future program and policy planning. Evidence Check questions This review aimed to address the following questions: 1. What is the evidence for the effectiveness of lung cancer screening for higher-risk individuals? 2. What is the evidence of potential harms from lung cancer screening for higher-risk individuals? 3. What are the main components of recent major lung cancer screening programs or trials? 4. What is the cost-effectiveness of lung cancer screening programs (include studies of cost–utility)? Summary of methods The authors searched the peer-reviewed literature across three databases (MEDLINE, PsycINFO and Embase) for existing systematic reviews and original studies published between 1 January 2009 and 8 August 2019. Fifteen systematic reviews (of which 8 were contemporary) and 64 original publications met the inclusion criteria set across the four questions. Key findings Question 1: What is the evidence for the effectiveness of lung cancer screening for higher-risk individuals? There is sufficient evidence from systematic reviews and meta-analyses of combined (pooled) data from screening trials (of high-risk individuals) to indicate that LDCT examination is clinically effective in reducing lung cancer mortality. In 2011, the landmark National Lung Cancer Screening Trial (NLST, a large-scale randomised controlled trial [RCT] conducted in the US) reported a 20% (95% CI 6.8% – 26.7%; P=0.004) relative reduction in mortality among long-term heavy smokers over three rounds of annual screening. High-risk eligibility criteria was defined as people aged 55–74 years with a smoking history of ≥30 pack-years (years in which a smoker has consumed 20-plus cigarettes each day) and, for former smokers, ≥30 pack-years and have quit within the past 15 years.(5) All-cause mortality was reduced by 6.7% (95% CI, 1.2% – 13.6%; P=0.02). Initial data from the second landmark RCT, the NEderlands-Leuvens Longkanker Screenings ONderzoek (known as the NELSON trial), have found an even greater reduction of 26% (95% CI, 9% – 41%) in lung cancer mortality, with full trial results yet to be published.(6, 7) Pooled analyses, including several smaller-scale European LDCT screening trials insufficiently powered in their own right, collectively demonstrate a statistically significant reduction in lung cancer mortality (RR 0.82, 95% CI 0.73–0.91).(8) Despite the reduction in all-cause mortality found in the NLST, pooled analyses of seven trials found no statistically significant difference in all-cause mortality (RR 0.95, 95% CI 0.90–1.00).(8) However, cancer-specific mortality is currently the most relevant outcome in cancer screening trials. These seven trials demonstrated a significantly greater proportion of early stage cancers in LDCT groups compared with controls (RR 2.08, 95% CI 1.43–3.03). Thus, when considering results across mortality outcomes and early stage cancers diagnosed, LDCT screening is considered to be clinically effective. Question 2: What is the evidence of potential harms from lung cancer screening for higher-risk individuals? The harms of LDCT lung cancer screening include false positive tests and the consequences of unnecessary invasive follow-up procedures for conditions that are eventually diagnosed as benign. While LDCT screening leads to an increased frequency of invasive procedures, it does not result in greater mortality soon after an invasive procedure (in trial settings when compared with the control arm).(8) Overdiagnosis, exposure to radiation, psychological distress and an impact on quality of life are other known harms. Systematic review evidence indicates the benefits of LDCT screening are likely to outweigh the harms. The potential harms are likely to be reduced as refinements are made to LDCT screening protocols through: i) the application of risk predication models (e.g. the PLCOm2012), which enable a more accurate selection of the high-risk population through the use of specific criteria (beyond age and smoking history); ii) the use of nodule management algorithms (e.g. Lung-RADS, PanCan), which assist in the diagnostic evaluation of screen-detected nodules and cancers (e.g. more precise volumetric assessment of nodules); and, iii) more judicious selection of patients for invasive procedures. Recent evidence suggests a positive LDCT result may transiently increase psychological distress but does not have long-term adverse effects on psychological distress or health-related quality of life (HRQoL). With regards to smoking cessation, there is no evidence to suggest screening participation invokes a false sense of assurance in smokers, nor a reduction in motivation to quit. The NELSON and Danish trials found no difference in smoking cessation rates between LDCT screening and control groups. Higher net cessation rates, compared with general population, suggest those who participate in screening trials may already be motivated to quit. Question 3: What are the main components of recent major lung cancer screening programs or trials? There are no systematic reviews that capture the main components of recent major lung cancer screening trials and programs. We extracted evidence from original studies and clinical guidance documents and organised this into key groups to form a concise set of components for potential implementation of a national lung cancer screening program in Australia: 1. Identifying the high-risk population: recruitment, eligibility, selection and referral 2. Educating the public, people at high risk and healthcare providers; this includes creating awareness of lung cancer, the benefits and harms of LDCT screening, and shared decision-making 3. Components necessary for health services to deliver a screening program: a. Planning phase: e.g. human resources to coordinate the program, electronic data systems that integrate medical records information and link to an established national registry b. Implementation phase: e.g. human and technological resources required to conduct LDCT examinations, interpretation of reports and communication of results to participants c. Monitoring and evaluation phase: e.g. monitoring outcomes across patients, radiological reporting, compliance with established standards and a quality assurance program 4. Data reporting and research, e.g. audit and feedback to multidisciplinary teams, reporting outcomes to enhance international research into LDCT screening 5. Incorporation of smoking cessation interventions, e.g. specific programs designed for LDCT screening or referral to existing community or hospital-based services that deliver cessation interventions. Most original studies are single-institution evaluations that contain descriptive data about the processes required to establish and implement a high-risk population-based screening program. Across all studies there is a consistent message as to the challenges and complexities of establishing LDCT screening programs to attract people at high risk who will receive the greatest benefits from participation. With regards to smoking cessation, evidence from one systematic review indicates the optimal strategy for incorporating smoking cessation interventions into a LDCT screening program is unclear. There is widespread agreement that LDCT screening attendance presents a ‘teachable moment’ for cessation advice, especially among those people who receive a positive scan result. Smoking cessation is an area of significant research investment; for instance, eight US-based clinical trials are now underway that aim to address how best to design and deliver cessation programs within large-scale LDCT screening programs.(9) Question 4: What is the cost-effectiveness of lung cancer screening programs (include studies of cost–utility)? Assessing the value or cost-effectiveness of LDCT screening involves a complex interplay of factors including data on effectiveness and costs, and institutional context. A key input is data about the effectiveness of potential and current screening programs with respect to case detection, and the likely outcomes of treating those cases sooner (in the presence of LDCT screening) as opposed to later (in the absence of LDCT screening). Evidence about the cost-effectiveness of LDCT screening programs has been summarised in two systematic reviews. We identified a further 13 studies—five modelling studies, one discrete choice experiment and seven articles—that used a variety of methods to assess cost-effectiveness. Three modelling studies indicated LDCT screening was cost-effective in the settings of the US and Europe. Two studies—one from Australia and one from New Zealand—reported LDCT screening would not be cost-effective using NLST-like protocols. We anticipate that, following the full publication of the NELSON trial, cost-effectiveness studies will likely be updated with new data that reduce uncertainty about factors that influence modelling outcomes, including the findings of indeterminate nodules. Gaps in the evidence There is a large and accessible body of evidence as to the effectiveness (Q1) and harms (Q2) of LDCT screening for lung cancer. Nevertheless, there are significant gaps in the evidence about the program components that are required to implement an effective LDCT screening program (Q3). Questions about LDCT screening acceptability and feasibility were not explicitly included in the scope. However, as the evidence is based primarily on US programs and UK pilot studies, the relevance to the local setting requires careful consideration. The Queensland Lung Cancer Screening Study provides feasibility data about clinical aspects of LDCT screening but little about program design. The International Lung Screening Trial is still in the recruitment phase and findings are not yet available for inclusion in this Evidence Check. The Australian Population Based Screening Framework was developed to “inform decision-makers on the key issues to be considered when assessing potential screening programs in Australia”.(10) As the Framework is specific to population-based, rather than high-risk, screening programs, there is a lack of clarity about transferability of criteria. However, the Framework criteria do stipulate that a screening program must be acceptable to “important subgroups such as target participants who are from culturally and linguistically diverse backgrounds, Aboriginal and Torres Strait Islander people, people from disadvantaged groups and people with a disability”.(10) An extensive search of the literature highlighted that there is very little information about the acceptability of LDCT screening to these population groups in Australia. Yet they are part of the high-risk population.(10) There are also considerable gaps in the evidence about the cost-effectiveness of LDCT screening in different settings, including Australia. The evidence base in this area is rapidly evolving and is likely to include new data from the NELSON trial and incorporate data about the costs of targeted- and immuno-therapies as these treatments become more widely available in Australia.
APA, Harvard, Vancouver, ISO, and other styles
2

NAVAL MEDICAL RESEARCH INST BETHESDA MD. Summaries of Research 1992 (Naval Medical Research Institute). Fort Belvoir, VA: Defense Technical Information Center, January 1992. http://dx.doi.org/10.21236/ada275367.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Smit, Amelia, Kate Dunlop, Nehal Singh, Diona Damian, Kylie Vuong, and Anne Cust. Primary prevention of skin cancer in primary care settings. The Sax Institute, August 2022. http://dx.doi.org/10.57022/qpsm1481.

Full text
Abstract:
Overview Skin cancer prevention is a component of the new Cancer Plan 2022–27, which guides the work of the Cancer Institute NSW. To lessen the impact of skin cancer on the community, the Cancer Institute NSW works closely with the NSW Skin Cancer Prevention Advisory Committee, comprising governmental and non-governmental organisation representatives, to develop and implement the NSW Skin Cancer Prevention Strategy. Primary Health Networks and primary care providers are seen as important stakeholders in this work. To guide improvements in skin cancer prevention and inform the development of the next NSW Skin Cancer Prevention Strategy, an up-to-date review of the evidence on the effectiveness and feasibility of skin cancer prevention activities in primary care is required. A research team led by the Daffodil Centre, a joint venture between the University of Sydney and Cancer Council NSW, was contracted to undertake an Evidence Check review to address the questions below. Evidence Check questions This Evidence Check aimed to address the following questions: Question 1: What skin cancer primary prevention activities can be effectively administered in primary care settings? As part of this, identify the key components of such messages, strategies, programs or initiatives that have been effectively implemented and their feasibility in the NSW/Australian context. Question 2: What are the main barriers and enablers for primary care providers in delivering skin cancer primary prevention activities within their setting? Summary of methods The research team conducted a detailed analysis of the published and grey literature, based on a comprehensive search. We developed the search strategy in consultation with a medical librarian at the University of Sydney and the Cancer Institute NSW team, and implemented it across the databases Embase, MEDLINE, PsycInfo, Scopus, Cochrane Central and CINAHL. Results were exported and uploaded to Covidence for screening and further selection. The search strategy was designed according to the SPIDER tool for Qualitative and Mixed-Methods Evidence Synthesis, which is a systematic strategy for searching qualitative and mixed-methods research studies. The SPIDER tool facilitates rigour in research by defining key elements of non-quantitative research questions. We included peer-reviewed and grey literature that included skin cancer primary prevention strategies/ interventions/ techniques/ programs within primary care settings, e.g. involving general practitioners and primary care nurses. The literature was limited to publications since 2014, and for studies or programs conducted in Australia, the UK, New Zealand, Canada, Ireland, Western Europe and Scandinavia. We also included relevant systematic reviews and evidence syntheses based on a range of international evidence where also relevant to the Australian context. To address Question 1, about the effectiveness of skin cancer prevention activities in primary care settings, we summarised findings from the Evidence Check according to different skin cancer prevention activities. To address Question 2, about the barriers and enablers of skin cancer prevention activities in primary care settings, we summarised findings according to the Consolidated Framework for Implementation Research (CFIR). The CFIR is a framework for identifying important implementation considerations for novel interventions in healthcare settings and provides a practical guide for systematically assessing potential barriers and facilitators in preparation for implementing a new activity or program. We assessed study quality using the National Health and Medical Research Council (NHMRC) levels of evidence. Key findings We identified 25 peer-reviewed journal articles that met the eligibility criteria and we included these in the Evidence Check. Eight of the studies were conducted in Australia, six in the UK, and the others elsewhere (mainly other European countries). In addition, the grey literature search identified four relevant guidelines, 12 education/training resources, two Cancer Care pathways, two position statements, three reports and five other resources that we included in the Evidence Check. Question 1 (related to effectiveness) We categorised the studies into different types of skin cancer prevention activities: behavioural counselling (n=3); risk assessment and delivering risk-tailored information (n=10); new technologies for early detection and accompanying prevention advice (n=4); and education and training programs for general practitioners (GPs) and primary care nurses regarding skin cancer prevention (n=3). There was good evidence that behavioural counselling interventions can result in a small improvement in sun protection behaviours among adults with fair skin types (defined as ivory or pale skin, light hair and eye colour, freckles, or those who sunburn easily), which would include the majority of Australians. It was found that clinicians play an important role in counselling patients about sun-protective behaviours, and recommended tailoring messages to the age and demographics of target groups (e.g. high-risk groups) to have maximal influence on behaviours. Several web-based melanoma risk prediction tools are now available in Australia, mainly designed for health professionals to identify patients’ risk of a new or subsequent primary melanoma and guide discussions with patients about primary prevention and early detection. Intervention studies have demonstrated that use of these melanoma risk prediction tools is feasible and acceptable to participants in primary care settings, and there is some evidence, including from Australian studies, that using these risk prediction tools to tailor primary prevention and early detection messages can improve sun-related behaviours. Some studies examined novel technologies, such as apps, to support early detection through skin examinations, including a very limited focus on the provision of preventive advice. These novel technologies are still largely in the research domain rather than recommended for routine use but provide a potential future opportunity to incorporate more primary prevention tailored advice. There are a number of online short courses available for primary healthcare professionals specifically focusing on skin cancer prevention. Most education and training programs for GPs and primary care nurses in the field of skin cancer focus on treatment and early detection, though some programs have specifically incorporated primary prevention education and training. A notable example is the Dermoscopy for Victorian General Practice Program, in which 93% of participating GPs reported that they had increased preventive information provided to high-risk patients and during skin examinations. Question 2 (related to barriers and enablers) Key enablers of performing skin cancer prevention activities in primary care settings included: • Easy access and availability of guidelines and point-of-care tools and resources • A fit with existing workflows and systems, so there is minimal disruption to flow of care • Easy-to-understand patient information • Using the waiting room for collection of risk assessment information on an electronic device such as an iPad/tablet where possible • Pairing with early detection activities • Sharing of successful programs across jurisdictions. Key barriers to performing skin cancer prevention activities in primary care settings included: • Unclear requirements and lack of confidence (self-efficacy) about prevention counselling • Limited availability of GP services especially in regional and remote areas • Competing demands, low priority, lack of time • Lack of incentives.
APA, Harvard, Vancouver, ISO, and other styles
4

Alcaide, C., A. O. Anderson, C. L. Bailey, K. Baksi, and M. A. Balady. U.S. Army Medical Research Institute of Infectious Diseases Annual Report, Fiscal Year 1986. Fort Belvoir, VA: Defense Technical Information Center, October 1986. http://dx.doi.org/10.21236/ada230324.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Amano, K. I., A. O. Anderson, C. L. Bailey, M. Balady, and R. F. Berendt. U.S. Army Medical Research Institute of Infectious Disease Annual Progress Report, Fiscal Year 1985. Fort Belvoir, VA: Defense Technical Information Center, October 1985. http://dx.doi.org/10.21236/ada230449.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

McEntee, Alice, Sonia Hines, Joshua Trigg, Kate Fairweather, Ashleigh Guillaumier, Jane Fischer, Billie Bonevski, James A. Smith, Carlene Wilson, and Jacqueline Bowden. Tobacco cessation in CALD communities. The Sax Institute, June 2022. http://dx.doi.org/10.57022/sneg4189.

Full text
Abstract:
Background Australia is a multi-cultural society with increasing rates of people from culturally and linguistically diverse (CALD) backgrounds. On average, CALD groups have higher rates of tobacco use, lower participation in cancer screening programs, and poorer health outcomes than the general Australian population. Lower cancer screening and smoking cessation rates are due to differing cultural norms, health-related attitudes, and beliefs, and language barriers. Interventions can help address these potential barriers and increase tobacco cessation and cancer screening rates among CALD groups. Cancer Council NSW (CCNSW) aims to reduce the impact of cancer and improve cancer outcomes for priority populations including CALD communities. In line with this objective, CCNSW commissioned this rapid review of interventions implemented in Australia and comparable countries. Review questions This review aimed to address the following specific questions: Question 1 (Q1): What smoking cessation interventions have been proven effective in reducing or preventing smoking among culturally and linguistically diverse communities? Question 2 (Q2): What screening interventions have proven effective in increasing participation in population cancer screening programs among culturally and linguistically diverse populations? This review focused on Chinese-, Vietnamese- and Arabic-speaking people as they are the largest CALD groups in Australia and have high rates of tobacco use and poor screening adherence in NSW. Summary of methods An extensive search of peer-reviewed and grey literature published between January 2013-March 2022 identified 19 eligible studies for inclusion in the Q1 review and 49 studies for the Q2 review. The National Health and Medical Research Council (NHMRC) Levels of Evidence and Joanna Briggs Institute’s (JBI) Critical Appraisal Tools were used to assess the robustness and quality of the included studies, respectively. Key findings Findings are reported by components of an intervention overall and for each CALD group. By understanding the effectiveness of individual components, results will demonstrate key building blocks of an effective intervention. Question 1: What smoking cessation interventions have been proven effective in reducing or preventing smoking among culturally and linguistically diverse communities? Thirteen of the 19 studies were Level IV (L4) evidence, four were Level III (L3), one was Level II (L2), none were L1 (highest level of evidence) and one study’s evidence level was unable to be determined. The quality of included studies varied. Fifteen tobacco cessation intervention components were included, with most interventions involving at least three components (range 2-6). Written information (14 studies), and education sessions (10 studies) were the most common components included in an intervention. Eight of the 15 intervention components explored had promising evidence for use with Chinese-speaking participants (written information, education sessions, visual information, counselling, involving a family member or friend, nicotine replacement therapy, branded merchandise, and mobile messaging). Another two components (media campaign and telephone follow-up) had evidence aggregated across CALD groups (i.e., results for Chinese-speaking participants were combined with other CALD group(s)). No intervention component was deemed of sufficient evidence for use with Vietnamese-speaking participants and four intervention components had aggregated evidence (written information, education sessions, counselling, nicotine replacement therapy). Counselling was the only intervention component to have promising evidence for use with Arabic-speaking participants and one had mixed evidence (written information). Question 2: What screening interventions have proven effective in increasing participation in population cancer screening programs among culturally and linguistically diverse populations? Two of the 49 studies were Level I (L1) evidence, 13 L2, seven L3, 25 L4 and two studies’ level of evidence was unable to be determined. Eighteen intervention components were assessed with most interventions involving 3-4 components (range 1-6). Education sessions (32 studies), written information (23 studies) and patient navigation (10 studies) were the most common components. Seven of the 18 cancer screening intervention components had promising evidence to support their use with Vietnamese-speaking participants (education sessions, written information, patient navigation, visual information, peer/community health worker, counselling, and peer experience). The component, opportunity to be screened (e.g. mailed or handed a bowel screening test), had aggregated evidence regarding its use with Vietnamese-speaking participants. Seven intervention components (education session, written information, visual information, peer/community health worker, opportunity to be screened, counselling, and branded merchandise) also had promising evidence to support their use with Chinese-speaking participants whilst two components had mixed (patient navigation) or aggregated (media campaign) evidence. One intervention component for use with Arabic-speaking participants had promising evidence to support its use (opportunity to be screened) and eight intervention components had mixed or aggregated support (education sessions, written information, patient navigation, visual information, peer/community health worker, peer experience, media campaign, and anatomical models). Gaps in the evidence There were four noteworthy gaps in the evidence: 1. No systematic review was captured for Q1, and only two studies were randomised controlled trials. Much of the evidence is therefore based on lower level study designs, with risk of bias. 2. Many studies provided inadequate detail regarding their intervention design which impacts both the quality appraisal and how mixed finding results can be interpreted. 3. Several intervention components were found to have supportive evidence available only at the aggregate level. Further research is warranted to determine the interventions effectiveness with the individual CALD participant group only. 4. The evidence regarding the effectiveness of certain intervention components were either unknown (no studies) or insufficient (only one study) across CALD groups. This was the predominately the case for Arabic-speaking participants for both Q1 and Q2, and for Vietnamese-speaking participants for Q1. Further research is therefore warranted. Applicability Most of the intervention components included in this review are applicable for use in the Australian context, and NSW specifically. However, intervention components assessed as having insufficient, mixed, or no evidence require further research. Cancer screening and tobacco cessation interventions targeting Chinese-speaking participants were more common and therefore showed more evidence of effectiveness for the intervention components explored. There was support for cancer screening intervention components targeting Vietnamese-speaking participants but not for tobacco cessation interventions. There were few interventions implemented for Arabic-speaking participants that addressed tobacco cessation and screening adherence. Much of the evidence for Vietnamese and Arabic-speaking participants was further limited by studies co-recruiting multiple CALD groups and reporting aggregate results. Conclusion There is sound evidence for use of a range of intervention components to address tobacco cessation and cancer screening adherence among Chinese-speaking populations, and cancer screening adherence among Vietnamese-speaking populations. Evidence is lacking regarding the effectiveness of tobacco cessation interventions with Vietnamese- and Arabic-speaking participants, and cancer screening interventions for Arabic-speaking participants. More research is required to determine whether components considered effective for use in one CALD group are applicable to other CALD populations.
APA, Harvard, Vancouver, ISO, and other styles
7

Moore, Melissa. Phase II - Procurement of State of the Art Research Equipment to Support Faculty Members with the RNA Therapeutics Institute, a component of the Advanced Therapeutics Cluster at the University of Massachusetts Medical School. Office of Scientific and Technical Information (OSTI), October 2011. http://dx.doi.org/10.2172/1037882.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Jones, Nicole S., Jeri D. Ropero-Miller, Heather Waltke, Danielle McLeod-Henning, Danielle Weiss, and Hannah Barcus. Proceedings of the International Forensic Radiology Research Summit May 10–11, 2016, Amsterdam, The Netherlands. RTI Press, September 2017. http://dx.doi.org/10.3768/rtipress.2017.cp.0005.1709.

Full text
Abstract:
On May 10–11, 2016, the US Department of Justice (DOJ) National Institute of Justice (NIJ), the Netherlands Forensic Institute (NFI; Dutch Ministry of Security and Justice of the Netherlands), the International Society for Forensic Radiology and Imaging (ISFRI), the International Association of Forensic Radiographers (IAFR), and NIJ’s Forensic Technology Center of Excellence (FTCoE) at RTI International organized and convened the International Forensic Radiology Research Summit (IFRRS) at the Academic Medical Center in Amsterdam. The summit assembled 40 international subject matter experts in forensic radiology, to include researchers, practitioners, government employees, and professional staff from 14 countries. The goal of this 2-day summit was to identify gaps, challenges, and research needs to produce a road map to success regarding the state of forensic radiology, including formulating a plan to address the obstacles to implementation of advanced imaging technologies in medicolegal investigations. These proceedings summarize the meeting’s important exchange of technical and operational information, ideas, and solutions for the community and other stakeholders of forensic radiology.
APA, Harvard, Vancouver, ISO, and other styles
9

Liu, Edgar, Malgorzata Lagisz, Evelyne de Leeuw, and Hyungmo Yang. Place-based Health Interventions in NSW - A rapid review of evidence. SPHERE HUE Collaboratory, November 2022. http://dx.doi.org/10.52708/pbhi-el.

Full text
Abstract:
This report describes a rapid review exercise on the place-based intervention approaches to improving the health and wellbeing outcomes of residents in the Australian state of New South Wales (NSW). The aim of this exercise is to inform the Cancer Institute NSW on their future policy and program developments in cancer prevention and screening. Specifically, it seeks to answer the following research questions: 1. What place-based interventions for health promotion and risk prevention and screening currently exist in NSW? 2. How effective have these interventions been in achieving their stated objectives?
APA, Harvard, Vancouver, ISO, and other styles
10

Norsworthy, Sarah, Rebecca Shute, Crystal M. Daye, and Paige Presler-Jur. National Institute of Justice’s Forensic Technology Center of Excellence 2019 National Opioid and Emerging Drug Threats Policy and Practice Forum. Edited by Jeri D. Ropero-Miller and Hope Smiley-McDonald. RTI Press, July 2020. http://dx.doi.org/10.3768/rtipress.2020.cp.0011.2007.

Full text
Abstract:
The National Institute of Justice (NIJ) and its Forensic Technology Center of Excellence (FTCoE) hosted the National Opioid and Emerging Drug Threats Policy and Practice Forum on July 18–19, 2019, in Washington, DC. The forum explored ways in which government agencies and programs, law enforcement officials, forensic laboratory personnel, medical examiners and coroners, researchers, and other experts can cooperate to respond to problems associated with drug abuse and misuse. Panelists from these stakeholder groups discussed ways to address concerns such as rapidly expanding crime laboratory caseloads; workforce shortages and resiliency programs; analytical challenges associated with fentanyl analogs and drug mixtures; laboratory quality control; surveillance systems to inform response; and policy related to stakeholder, research, and resource constraints. The NIJ Policy and Practice Forum built off the momentum of previous stakeholder meetings convened by NIJ and other agencies to discuss the consequences of this national epidemic, including the impact it has had on public safety, public health, and the criminal justice response. The forum discussed topics at a policy level and addressed best practices used across the forensic community.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Australian Medical Research Institute' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography